Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations-Reference-Cited by-同舟云学术

Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations

Published:2017-07 Issue:7 Volume:187 Page:1512-1522
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Guo Belinda B.,Allcock Richard J.,Mirzai Bob,Malherbe Jacques A.,Choudry Fizzah A.,Frontini Mattia,Chuah Hun,Liang James,Kavanagh Simon E.,Howman Rebecca,Ouwehand Willem H.,Fuller Kathryn A.,Erber Wendy N.

Funder

Cancer Council Western Australia

Anne Helene Oakley Trust

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference53 articles.

1. Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies;Tefferi;J Clin Oncol,2011

2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

3. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms;Tefferi;Leukemia,2008

4. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel;Tefferi;Blood,2007

5. A gain-of-function mutation of JAK2 in myeloproliferative disorders;Kralovics;N Engl J Med,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia;Journal of Hematology & Oncology;2024-06-09

2. Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis;Platelets;2024-02

3. Germline heterozygous SH2B3‐mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutation;eJHaem;2023-10-27

4. Variants of HCMV UL18 Sequenced Directly from Clinical Specimens Associate with Antibody and T-Cell Responses to HCMV;International Journal of Molecular Sciences;2022-10-26

5. Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms;Cancers;2022-02-15